07/04/2025 14:24
EQS-News: OTRS AG: Voluntary Public Tender Offer of Optimus BidCo AG
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: OTRS AG / Key words: Tender Offer br/ OTRS AG: Voluntary Public Tender Offer of Optimus BidCo AG br/br/ 07.04.2025 / 14:24 CET/CESTbr/ The issuer is solely... Lire...
07/04/2025 14:00
AI/ML Innovations, Inc. : AIML Updates Terms of Proposed Private Placement Announced
pstrong id=datelineVANCOUVER, BC / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 7, 2025 / /strongstrongAI/ML Innovations Inc/strong. "strongAIML/strong" or the "strongCompany/strong" CSE:AIMLOTCQB:AIMLFFWB:42FB is pleased to announce that it intends to... Lire...
07/04/2025 14:00
GPO Plus, Inc. : GPOX Reports Record Quarterly Revenue with Significantly Improved Gross Margins
ullipistrongGross Revenues Up 11% YTD with 30% Reduction in Operating Expenses/strong/i/p/lilipistrongGross Margins Improve from 15% to 28% as Company Prepares to Scale/strong/i/p/li/ul pstrong id=datelineLAS VEGAS, NEVADA / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 7, 2025 /... Lire...
07/04/2025 14:00
Newsmax Inc. : Newsmax’s Audience Grows by 50% in Q1 2025
pstrong id=datelineBOCA RATON, FL / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 7, 2025 / /strongstrongNewsmax Inc. NYSE:NMAX /strong"Newsmax" or the "Company" announced today that its total audience is continuing to surge, growing by an eyepopping 50% from... Lire...
07/04/2025 14:00
Tharimmune Inc. : Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
pstrong id=datelineBRIDGEWATER, NJ / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 7, 2025 / /strongTharimmune, Inc. Nasdaq:THAR "Tharimmune" or the "Company", a clinicalstage biotechnology company focused on immunology and inflammation, today announced... Lire...
07/04/2025 14:00
Rio Grande Resources : Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
pstrong id=datelineVANCOUVER, BC / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 7, 2025 / /strongstrongRio Grande Resources Ltd./strong strongCSE:RGROTC PINK:RGRLF/strong "strongRio Grande/strong" or "strongRIO/strong" the "strongCompany/strong", is... Lire...
07/04/2025 14:00
NOA Lithium Brines Inc. : NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
pistrongDrilling operations at the Companys flagship Rio Grande Project are scheduled to commence within the next 20 days/strong/i/ppstrongBUENOS AIRES, ARGENTINA / /stronga href=https://www.accessnewswire.com/ rel=nofollowstrongACCESS Newswire/strong/astrong / April 7, 2025 / NOA Lithium Brines... Lire...
07/04/2025 13:30
Orogen Royalties Inc : Orogen Royalties Announces Mineral Resource and Reserve Update on Producing Ermitaño Royalty Including Initial Inferred Resource for the Navidad Vein
pstrong id=datelineVANCOUVER, BC / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 7, 2025 / /strongstrongTSX.V:OGNOTCQX:OGNRF /strongOrogen Royalties Inc. "Orogen" or the "Company" is pleased to announce an update to the mineral reserve and resource estimates on... Lire...
07/04/2025 13:00
EQS-News: CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p Issuer: CureVac / Key words: Study/Regulatory Approval br/ CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNABased Precision Immunotherapy in Squamous... Lire...